USD
+$0.00
(+0.00%
)At Close (As of Sep 5, 2025)
$766.94K
Market Cap
-
P/E Ratio
-46.06
EPS
$44.50
52 Week High
$0.10
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | -$31K |
Total Revenue | $0 |
Cost Of Revenue | $31K |
Costof Goods And Services Sold | $31K |
Operating Income | -$19M |
Selling General And Administrative | $7.5M |
Research And Development | $12M |
Operating Expenses | $19M |
Investment Income Net | - |
Net Interest Income | -$1.2M |
Interest Income | - |
Interest Expense | $1.2M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | -$1.9M |
Income Before Tax | -$16M |
Income Tax Expense | -$3M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$13M |
Comprehensive Income Net Of Tax | - |
Ebit | -$17M |
Ebitda | -$19M |
Net Income | -$13M |
Field | Value (USD) |
---|---|
Total Assets | $1.6M |
Total Current Assets | $1.6M |
Cash And Cash Equivalents At Carrying Value | $406K |
Cash And Short Term Investments | $406K |
Inventory | - |
Current Net Receivables | - |
Total Non Current Assets | $607K |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $1.2M |
Other Non Current Assets | - |
Total Liabilities | $3.5M |
Total Current Liabilities | $3.1M |
Current Accounts Payable | $220K |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $2.9M |
Total Non Current Liabilities | $333K |
Capital Lease Obligations | $0 |
Long Term Debt | - |
Current Long Term Debt | $2.9M |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $2.9M |
Other Current Liabilities | $24K |
Other Non Current Liabilities | - |
Total Shareholder Equity | -$1.9M |
Treasury Stock | - |
Retained Earnings | -$238M |
Common Stock | $14 |
Common Stock Shares Outstanding | $123K |
Field | Value (USD) |
---|---|
Operating Cashflow | -$18M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $31K |
Capital Expenditures | $3 |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | -$600K |
Cashflow From Financing | $4.3M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$13M |
Field | Value (USD) |
---|---|
Gross Profit | -$31K |
Total Revenue | $0 |
Cost Of Revenue | $31K |
Costof Goods And Services Sold | $31K |
Operating Income | -$19M |
Selling General And Administrative | $7.5M |
Research And Development | $12M |
Operating Expenses | $19M |
Investment Income Net | - |
Net Interest Income | -$1.2M |
Interest Income | - |
Interest Expense | $1.2M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | -$1.9M |
Income Before Tax | -$16M |
Income Tax Expense | -$3M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$13M |
Comprehensive Income Net Of Tax | - |
Ebit | -$17M |
Ebitda | -$19M |
Net Income | -$13M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, is focused on developing drug treatments for chronic liver disease in the United States. The company is headquartered in Edison, New Jersey.